FDA

In a landmark shift in how mental health conditions are treated in the near future, the US Food and Drug Administration has approved the first at-home brain-stimulation device that can rapidly relieve moderate to severe depression symptoms.

Millions of Americans can now look forward to a better time traveling, with the US Food and Drug Administration approving a novel oral pill that helps prevent motion-induced vomiting – the first of its kind in more than 40 years.

The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving Novo Nordisk's highly anticipated oral GLP-1 drug – with a starting dose available in early January for US$149.

The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease patients, aiming to prevent a common and costly issue that results in more than a million hospitalizations each year.

The FDA has approved a new version of an Alzheimer’s disease drug that can be given as a quick at-home weekly injection, offering patients a more convenient option than lengthy infusion-center visits. It will be widely available from October 6, 2025.

The first aceclidine-based eye drop to improve near vision in adults with age-related presbyopia, which affects more than 100 million adults in the US alone, has been approved by the Food and Drug Administration and will be on sale by November.

The US Food and Drug Administration has instructed all GLP-1 drug-makers to update warning labels to include the risk of serious kidney injury that can result from dehydration. This comes after cases of acute kidney injury have required hemodialysis.

In a comprehensive new study looking at 39,763 different foods and drinks from the biggest 25 companies in the country, scientists discovered that almost 20% rely on synthetic food dyes to attract consumers. Now, the fight is on to ban them for good.

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy approved for a Phase I clinical trial. It's a historical milestone that could reverse what has, until now, been an incurable injury.

A new antibiotic to relieve stubborn urinary tract infections and a blood-clot dissolving treatment for acute ischemic stroke will be commercially available in the coming months. It's been nearly three decades since adjacent drugs have hit the market.

Americans will soon have access to an infusion treatment that provides round-the-clock relief of Parkinson's symptoms. The US FDA has green-lit this innovative drug delivery system, which is expected to be available in the fourth quarter of 2025.

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found promise in permanently eliminating the virus, thanks to a drug already approved by the FDA to fight cancer.